Differential gene expression profiles during embryonic heart development in diabetic mice pregnancy

Gene

Volumn 516, Issue 2, 2013, Pages 218-227

  Vijaya, Murugaiyan ^a   Manikandan, Jayapal ^b   Parakalan, Rangarajan ^a   Dheen, S Thameem ^a   Kumar, Srinivasan Dinesh ^a,c   Tay, Samuel Sam Wah ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Diabetes; Embryo; Heart; Mice; Microarray

Indexed keywords

OLIGONUCLEOTIDE;

APOPTOSIS; ARTICLE; BIOINFORMATICS; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DEVELOPMENTAL GENE; EMBRYO; EMBRYO DEVELOPMENT; EMBRYOPATHY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HEART DEVELOPMENT; MATERNAL DIABETES MELLITUS; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; CLUSTER ANALYSIS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART; MALE; MICE; MICROARRAY ANALYSIS; MYOCARDIUM; PREGNANCY; PREGNANCY IN DIABETICS; PRENATAL EXPOSURE DELAYED EFFECTS; STREPTOZOCIN; TRANSCRIPTOME; VALIDATION STUDIES AS TOPIC;

MUS;

EID: 84873254227     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2012.12.071     Document Type: Article

References (48)

1. Aase K., et al. Angiomotin regulates endothelial cell migration during embryonic angiogenesis. Genes Dev. 2007, 21:2055-2068.
2. Aberg A., Westbom L., Kallen B. Congenital malformations among infants whose mothers had gestational diabetes or preexisting diabetes. Early Hum. Dev. 2001, 61:85-95.
3. Becerra J.E., Khoury M.J., Cordero J.F., Erickson J.D. Diabetes mellitus during pregnancy and the risks for specific birth defects: a population-based case-control study. Pediatrics 1990, 85:1-9.
4. Bolos V., Grego-Bessa J., de la Pompa J.L. Notch signaling in development and cancer. Endocr. Rev. 2007, 28:339-363.
5. Boyle S., Shioda T., Perantoni A.O., de Caestecker M. Cited1 and Cited2 are differentially expressed in the developing kidney but are not required for nephrogenesis. Dev. Dyn. 2007, 236:2321-2330.
6. Combs M.D., Yutzey K.E. VEGF and RANKL regulation of NFATc1 in heart valve development. Circ. Res. 2009, 105:565-574.
7. Correa A., et al. Diabetes mellitus and birth defects. Am. J. Obstet. Gynecol. 2008, 199:237. (e1-9).
8. Eriksson U.J. Congenital malformations in diabetic animal models-a review. Diabetes Res. 1984, 1:57-66.
9. Eriksson U.J. Congenital anomalies in diabetic pregnancy. Semin. Fetal Neonatal. Med. 2009, 14:85-93.
10. Eriksson U.J., Cederberg J., Wentzel P. Congenital malformations in offspring of diabetic mothers-animal and human studies. Rev. Endocr. Metab. Disord. 2003, 4:79-93.
11. Ferencz C., Rubin J.D., McCarter R.J., Clark E.B. Maternal diabetes and cardiovascular malformations: predominance of double outlet right ventricle and truncus arteriosus. Teratology 1990, 41:319-326.
12. Garg V., et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature 2003, 424:443-447.
13. Henderson D.J., Copp A.J. Versican expression is associated with chamber specification, septation, and valvulogenesis in the developing mouse heart. Circ. Res. 1998, 83:523-532.
14. Huang G.Y., Wessels A., Smith B.R., Linask K.K., Ewart J.L., Lo C.W. Alteration in connexin 43 gap junction gene dosage impairs conotruncal heart development. Dev. Biol. 1998, 198:32-44.
15. Jiang B., et al. Global gene expression analysis of cranial neural tubes in embryos of diabetic mice. J. Neurosci. Res. 2008, 86:3481-3493.
16. Junod A., Lambert A.E., Orci L., Pictet R., Gonet A.E., Renold A.E. Studies of the diabetogenic action of streptozotocin. Proc. Soc. Exp. Biol. Med. Soc. Exp. Biol. Med. 1967, 126:201-205.
17. Kirby M.L., Turnage K.L., Hays B.M. Characterization of conotruncal malformations following ablation of "cardiac" neural crest. Anat. Rec. 1985, 213:87-93.
18. Kumar S.D., Dheen S.T., Tay S.S. Maternal diabetes induces congenital heart defects in mice by altering the expression of genes involved in cardiovascular development. Cardiovasc. Diabetol. 2007, 6:34.
19. Kumar S.D., Yong S.-K., Dheen S.T., Bay B.-H., Tay S.S.-W. Cardiac malformations are associated with altered expression of vascular endothelial growth factor and endothelial nitric oxide synthase genes in embryos of diabetic mice. Exp. Biol. Med. 2008, 233:1421-1432.
20. Kumar S.D., et al. Zinc supplementation prevents cardiomyocyte apoptosis and congenital heart defects in embryos of diabetic mice. Free Radic. Biol. Med. 2012, 53:1595-1606.
21. Li W.E., et al. An essential role for connexin43 gap junctions in mouse coronary artery development. Development 2002, 129:2031-2042.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Lo C.W., Waldo K.L., Kirby M.L. Gap junction communication and the modulation of cardiac neural crest cells. Trends Cardiovasc. Med. 1999, 9:63-69.
24. Luo Y., High F.A., Epstein J.A., Radice G.L. N-cadherin is required for neural crest remodeling of the cardiac outflow tract. Dev. Biol. 2006, 299:517-528.
25. Mills J.L. Malformations in infants of diabetic mothers. Teratology 1982, 25:385-394.
26. Birth Defects Res. A Clin. Mol. Teratol. 2010, 88:769-778.
27. Mjaatvedt C.H., Yamamura H., Capehart A.A., Turner D., Markwald R.R. The Cspg2 gene, disrupted in the hdf mutant, is required for right cardiac chamber and endocardial cushion formation. Dev. Biol. 1998, 202:56-66.
28. Molin D.G., et al. Disturbed morphogenesis of cardiac outflow tract and increased rate of aortic arch anomalies in the offspring of diabetic rats. Birth Defects Res. A Clin. Mol. Teratol. 2004, 70:927-938.
29. Morgan S.C., Relaix F., Sandell L.L., Loeken M.R. Oxidative stress during diabetic pregnancy disrupts cardiac neural crest migration and causes outflow tract defects. Birth Defects Res. A Clin. Mol. Teratol. 2008, 82:453-463.
30. Park C.Y., et al. skNAC, a Smyd1-interacting transcription factor, is involved in cardiac development and skeletal muscle growth and regeneration. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20750-20755.
31. Pavlinkova G., Salbaum J.M., Kappen C. Maternal diabetes alters transcriptional programs in the developing embryo. BMC Genomics 2009, 10:274.
32. Piven O.O., Kostetskii I.E., Macewicz L.L., Kolomiets Y.M., Radice G.L., Lukash L.L. Requirement for N-cadherin-catenin complex in heart development. Exp. Biol. Med. (Maywood) 2011, 236:816-822.
33. Reaume A.G., et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995, 267:1831-1834.
34. Reece E.A., Ji I., Wu Y.K., Zhao Z. Characterization of differential gene expression profiles in diabetic embryopathy using DNA microarray analysis. Am. J. Obstet. Gynecol. 2006, 195:1075-1080.
35. Rodriguez T.A., et al. Cited1 is required in trophoblasts for placental development and for embryo growth and survival. Mol. Cell. Biol. 2004, 24:228-244.
36. Samuel L.J., Latinkic B.V. Early activation of FGF and nodal pathways mediates cardiac specification independently of Wnt/beta-catenin signaling. PLoS One 2009, 4:e7650.
37. Schneider J.E., et al. Identification of cardiac malformations in mice lacking Ptdsr using a novel high-throughput magnetic resonance imaging technique. BMC Dev. Biol. 2004, 4:16.
38. Shimono A., Behringer R.R. Angiomotin regulates visceral endoderm movements during mouse embryogenesis. Curr. Biol. 2003, 13:613-617.
39. Singh M.K., et al. Gata4 and Gata5 cooperatively regulate cardiac myocyte proliferation in mice. J. Biol. Chem. 2010, 285:1765-1772.
40. Soler N.G., Walsh C.H., Malins J.M. Congenital malformations in infants of diabetic mothers. Q. J. Med. 1976, 45:303-313.
41. Tanaka M., Chen Z., Bartunkova S., Yamasaki N., Izumo S. The cardiac homeobox gene Csx/Nkx2.5 lies genetically upstream of multiple genes essential for heart development. Development 1999, 126:1269-1280.
42. Wang H., Yan Y., Li B., Bi L., Wu L. Hierarchical self-assembly of surfactant-encapsulated and organically grafted polyoxometalate complexes. Chemistry 2011, 17:4273-4282.
43. Wentzel P. Can we prevent diabetic birth defects with micronutrients?. Diabetes Obes. Metab. 2009, 11:770-778.
44. Wren C., Birrell G., Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart 2003, 89:1217-1220.
45. Xu X., et al. Modulation of mouse neural crest cell motility by N-cadherin and connexin 43 gap junctions. J. Cell Biol. 2001, 154:217-230.
46. Ya J., et al. Heart defects in connexin43-deficient mice. Circ. Res. 1998, 82:360-366.
47. Yim S.H., et al. Disruption of the Arnt gene in endothelial cells causes hepatic vascular defects and partial embryonic lethality in mice. Hepatology 2006, 44:550-560.
48. Zhou B., Wu B., Tompkins K.L., Boyer K.L., Grindley J.C., Baldwin H.S. Characterization of Nfatc1 regulation identifies an enhancer required for gene expression that is specific to pro-valve endocardial cells in the developing heart. Development 2005, 132:1137-1146.